NexImmune, Inc.: Private IO company developing unique approach to antigen-specific T cell therapy. Synthetic nanoparticles decorated w a combo of multiple tumor relevant antigens and co-stimulatory signals engaging directly w targeted T cells to orchestrate specific immune responses to cancer. Product applications as both SQ injectable and adoptively transferred cellular therapy. Multiple IND filings exp H1'19.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Disease Space
Immuno-Oncology
Listing
Private
Website:
Address:
9119 Gaither Road
Gaithersburg, MD 20877
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Solebury Trout Management Access: SF 2020

San Francisco, CA, United States, January 13 – January 16, 2020